Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug;36 Suppl 2(Suppl 2):S325-30.
doi: 10.2337/dcS13-2038.

Intolerance to statins: mechanisms and management

Affiliations
Review

Intolerance to statins: mechanisms and management

Rafael Bitzur et al. Diabetes Care. 2013 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed algorithm for the management of statin-associated myopathy. ULN, upper limit of normal.

References

    1. Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 2009;169:260–268 - PubMed
    1. Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther 2008;30:2167–2179 - PubMed
    1. Bays H. Statin safety: an overview and assessment of the data—2005. Am J Cardiol 2006;97:6C–26C - PubMed
    1. Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study. Cardiovasc Drugs Ther 2005;19:403–414 - PubMed
    1. Buettner C, Rippberger MJ, Smith JK, Leveille SG, Davis RB, Mittleman MA. Statin use and musculoskeletal pain among adults with and without arthritis. Am J Med 2012;125:176–182 - PMC - PubMed

MeSH terms

Substances